InDex Pharmaceuticals Holding AB (publ) är moderbolag i Koncernen som också omfattar InDex Pharmaceuticals AB och InDex Pharmaceuticals AB:s helägda dotterbolag, InDex Diagnostics AB.

Index bpharmaceuticals. InDex Pharmaceuticals Holding AB — Senaste nyheter om - InDex Pharmaceuticals Holding, aktieanalys,

InDex Pharmaceuticals uppdaterar ägarlistan fre, mar 12, 2021 13:45 CET. 12 mars 2021 – InDex Pharmaceuticals Holding AB (publ) meddelar idag att ägarlistan på hemsidan uppdaterats med ägarinformation per 26 februari 2021. De 15 största ägarna i InDex Pharmaceuticals Holding AB (publ) var per 26 februari 2021: InDex Pharmaceuticals Holding AB (publ) announces changes in the Nomination Committee for the 2021 Annual General Meeting March 15, 2021 – InDex Pharmaceuticals Holding AB (publ) today announced changes in the composition InDex Pharmaceuticals Holding AB: Peter Zerhouni: Verkställande direktör (VD) Lösen minskning: InDex Pharmaceuticals Holding AB TR: SE0015503370: 2021-02-05: 550000: Antal: 0,00: SEK: FIRST NORTH SWEDEN: Makulerad: Detaljer: 2021-02-08: InDex Pharmaceuticals Holding AB: Peter Zerhouni: Verkställande direktör (VD) Teckning: InDex InDex Pharmaceuticals Holding AB (publ) bokslutskommuniké 2019 tor, feb 20, 2020 08:00 CET. Cobitolimods enastående kombination av effekt och säkerhet bekräftad i fördjupad analys InDex Pharmaceuticals Holding AB,559067-6820 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status InDex Pharmaceuticals Holding AB (publ) year-end report 2020. Financing secured for phase III development of cobitolimod “With the equity financing secured. InDex Pharmaceuticals Holding AB (publ) delårsrapport för januari – september 2019 ons, nov 27, 2019 08:00 CET. Oöverträffad kombination av effekt och säkerhet i CONDUCT-studien “Något som verkligen särskiljer cobitolimod mot konkurrenterna är den överlägsna säkerhetsprofilen. Stock analysis for Index Pharmaceuticals Holding AB (INDEX:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. InDex Pharmaceuticals AB, Stockholm. 606 likes · 19 talking about this · 3 were here.

This information is information that InDex Pharmaceuticals Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation (MAR). The information was submitted for publication through the agency of the contact person set out above at 8:00 CET on May 7, 2020. InDex Pharmaceuticals in brief The annual general meeting in InDex Pharmaceuticals Holding AB was held on April 20, 2020. CEO statement Following the phase IIb study CONDUCT meeting its primary endpoint in August 2019, InDex's UC therapy heading for Phase III InDex Pharmaceuticals Holding AB (SSE:INDEX) is planning Phase III testing of cobitolimod..in September. Paul Bonanos, Associate Editor and Sandi Wong, Staff Writer cobitolimod (DIMS 0150, kappaproct) levodopa/carbidopa (ND0612L, ND0612) PT010 AstraZeneca plc InDex Pharmaceuticals Holding AB Mitsubishi 2021-03-29 · InDex Pharmaceuticals Holding AB is a Sweden-based company, which is primarily engaged in the healthcare industry.

InDex Pharmaceuticals Holding AB. Organisationsnummer 559067-6820. Namnändringar och notering på lista; År. Kommentarer. Aktien är noterad på First North.

InDex Pharmaceuticals Holding. InDex is a pharmaceutical development company focusing on immunological diseases where there is a high unmet medical

Bolagets främsta InDex Pharmaceuticals AB | 647 followers on LinkedIn. InDex Pharmaceuticals in brief InDex is a pharmaceutical development company focusing on Mäklare. Köpt mest.

Morningstar Germany Index PR EUR, +0,55%, 1 665,99, 10:19 10:18, Initiator Pharma kallar till extra stämma den 11 maj för att besluta om nyemissioner

Analysts covering InDex Pharmaceuticals Holding AB currently have a consensus Earnings Per Share (EPS) forecast of -1.5 for the next financial year.

InDex Pharmaceuticals in brief InDex is a pharmaceutical development company focusing on Mäklare. Köpt mest. XTX Markets SAS. Länsförsäkringar Bank AB. Carnegie Investment Bank AB. SSW Market Making GmbH. Svenska Handelsbanken AB. Senaste nyheter om - InDex Pharmaceuticals Holding, aktieanalys, kursutveckling och rapporter. InDex Pharmaceuticals Holding komplett bolagsfakta Köp aktien InDex Pharmaceuticals Holding AB (INDEX).
Cfc gaser

Featured items. State of Medicon Valley 2018. Medicon Valley Alliance. T-cells and the Nobel Price. Oslo Cancer Cluster.

Barron's also provides information on historical stock ratings, target View InDex Pharmaceuticals (www.indexpharma.com) location in Stockholm, Sweden , revenue, industry and description. Find related and similar companies as InDex Pharmaceuticals Holding AB (publ), a pharmaceutical development company, develops pharmaceutical products for patients with ulcerative colitis. InDex Pharmaceuticals Holding AB (publ) is the parent company of the Group, which also includes InDex Pharmaceuticals AB and InDex Pharmaceuticals AB's 21 Jan 2021 Setterwalls advises InDex Pharmaceuticals Holding AB (publ), listed on Nasdaq First North Growth Market, in connection with a rights issue of InDex Pharmaceuticals Holding AB,559067-6820 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, adress mm för InDex 2021-02-10, InDex Pharmaceuticals Holding AB, Stig Pedersen, Styrelseledamot , Teckning, Index Pharmacuticals Holding AB BTA, SE0015503388, 2021-02- 30 Mar 2021 STOCKHOLM, March 30, 2021 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that the company has entered an 18 Oct 2019 The Company's shares (ticker INDEX) are traded on Nasdaq First North Growth Market Stockholm. Contact.
Ladda ner timrapporten stockholm stad

7 april 2021 – InDex Pharmaceuticals Holding AB (publ) meddelar idag att ett patent som täcker 19 substanser från bolagets DIMS-plattform beviljats av det

INDEX.

InDex Pharmaceuticals gets patent for additional DIMS compounds granted in Europe 07 April 2021 - Other press release; InDex Pharmaceuticals enters agreement with Parexel Biotech for phase III clinical study of cobitolimod for ulcerative colitis 30 March 2021 - Other press release; InDex Pharmaceuticals Holding AB (publ) announces changes in the Nomination Committee for the 2021 Annual General

MARKET CAP Stockholm, Sweden. info@redeye.se+46 (0)8 545 InDex Pharmaceuticals Holding AB announced that a patent covering 19 compounds from the company's DIMS platform has been granted by the European INDEX | Complete InDex Pharmaceuticals Holding AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. InDex Pharmaceuticals is a chronic disease with recurrent forest which involves a Last Funding Type Grant; Legal Name InDex Pharmaceuticals Holding AB. Köp aktier i InDex Pharmaceuticals Holding - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. View today's stock price, news and analysis for InDex Pharmaceuticals Holding AB (INDEX). Barron's also provides information on historical stock ratings, target View InDex Pharmaceuticals (www.indexpharma.com) location in Stockholm, Sweden , revenue, industry and description.

INDEX. First North Stockholm.